Iovance Share Price

Iovance Share Price

NASDAQ: IOVA | Micro Cap | Healthcare
$6.90
-$0.39 (-5.35%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Iovance Stock Performance

Open
$7.11
Prev. Close
$7.29
Circuit Range
N/A
Day Range
$6.78 - $7.39
Year Range
$2.09 - $15.35
Volume
8,39,501
Average Traded
$6.98

Iovance Share Price Today

As of 22 November 2026, Iovance Biotherapeutics, Inc.'s share price is $6.90. The stock opened at $7.11, compared to its previous close of $7.29. During today's trading session, Iovance Biotherapeutics, Inc.'s share price traded between $6.78 and $7.39, with an average price of $7.08. Over the past 52 weeks, the stock has recorded a high of $15.35 and a low of $2.09. In terms of performance, Iovance Biotherapeutics, Inc.'s share price has risen by 68.29% over the last six months and is up 179.92% on a year-on-year basis.

Iovance Share Price Chart

Line chart of the Iovance price trend over the selected period. The price fell overall, ranging from 6.79 to 7.38, ending at 6.90.
$6.78$7.39
L
Show Current Price
H

Iovance Stock Fundamentals & Key Indicators

Market Cap
$2.47M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.48
Revenue (TTM)
$263.50B
Return On Equity (TTM)
-27.14%
Profit Margin
-148.38%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
69.03%

Iovance Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$86.77$71.43$99.31$121.47
Net Profit-$71.90-$79.05-$47.32-$22.27
Net Profit Margin-82.86%-110.67%-47.65%-18.33%
Income ChangeN/A-9.94%40.14%52.94%

Iovance Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$1.19$164.07$263.50
Net Profit-$395.89-$444.04-$372.18-$390.98
Net Profit MarginN/A-37314.29%-226.84%-148.38%
Income ChangeN/A-12.16%16.18%-5.05%

Iovance Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets470.48453.41472.5184.87
Current Assets442.69457.02307.85479.12
Total Assets913.17910.43780.35663.98
Non Current Liabilities76.2377.6885.4372.86
Current Liabilities138.36122.34110.3191.49
Total Liabilities214.59200.02195.74164.34
Shareholders' Equity698.58710.41584.61499.64

Iovance Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-302.41-352.98-361.82-292.76
Investing47.5-96.41-155.24256.46
Financing300.77390.66462.96190.15

About Iovance

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Iovance Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$8.50
$6.89
-18.26%
Oct 2026
$14.76
$8.44
-43.08%
Sep 2026
$8.02
$14.82
+79.20%
Aug 2026
$4.11
$8.27
+103.74%
Jul 2026
$4.17
$4.06
-2.43%
Jun 2026
$4.15
$4.16
+1.46%
May 2026
$3.37
$4.10
+22.39%
Apr 2026
$3.60
$3.35
-4.56%
Mar 2026
$3.67
$3.51
-9.54%
Feb 2026
$2.53
$3.88
+52.76%
Jan 2026
$2.78
$2.54
-6.96%
Dec 2025
$2.40
$2.73
+10.75%

Iovance Share Price FAQs